X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TORRENT PHARMA - Comparison Results

WOCKHARDT    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT TORRENT PHARMA WOCKHARDT/
TORRENT PHARMA
 
P/E (TTM) x -14.0 37.5 - View Chart
P/BV x 1.7 6.6 25.1% View Chart
Dividend Yield % 0.0 0.8 0.3%  

Financials

 WOCKHARDT   TORRENT PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
TORRENT PHARMA
Mar-18
WOCKHARDT/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0121,550 65.3%   
Low Rs5321,144 46.5%   
Sales per share (Unadj.) Rs355.9354.7 100.3%  
Earnings per share (Unadj.) Rs-60.340.1 -150.4%  
Cash flow per share (Unadj.) Rs-46.864.2 -72.8%  
Dividends per share (Unadj.) Rs0.0114.00 0.1%  
Dividend yield (eoy) %01.0 0.1%  
Book value per share (Unadj.) Rs257.8273.1 94.4%  
Shares outstanding (eoy) m110.63169.22 65.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.8 57.1%   
Avg P/E ratio x-12.833.6 -38.1%  
P/CF ratio (eoy) x-16.521.0 -78.7%  
Price / Book Value ratio x3.04.9 60.7%  
Dividend payout %034.9 -0.0%   
Avg Mkt Cap Rs m85,379227,897 37.5%   
No. of employees `0006.314.7 42.5%   
Total wages/salary Rs m9,37111,353 82.5%   
Avg. sales/employee Rs Th6,295.04,083.0 154.2%   
Avg. wages/employee Rs Th1,498.3772.3 194.0%   
Avg. net profit/employee Rs Th-1,066.3461.3 -231.1%   
INCOME DATA
Net Sales Rs m39,36960,021 65.6%  
Other income Rs m1,2022,988 40.2%   
Total revenues Rs m40,57163,009 64.4%   
Gross profit Rs m1813,493 0.1%  
Depreciation Rs m1,4954,086 36.6%   
Interest Rs m2,5553,085 82.8%   
Profit before tax Rs m-2,8309,310 -30.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2572,529 10.2%   
Profit after tax Rs m-6,6696,781 -98.3%  
Gross profit margin %022.5 0.2%  
Effective tax rate %-9.127.2 -33.4%   
Net profit margin %-16.911.3 -149.9%  
BALANCE SHEET DATA
Current assets Rs m33,79652,623 64.2%   
Current liabilities Rs m26,91752,022 51.7%   
Net working cap to sales %17.51.0 1,743.5%  
Current ratio x1.31.0 124.1%  
Inventory Days Days79120 66.3%  
Debtors Days Days8976 117.1%  
Net fixed assets Rs m39,66485,016 46.7%   
Share capital Rs m553846 65.4%   
"Free" reserves Rs m27,96845,376 61.6%   
Net worth Rs m28,52246,222 61.7%   
Long term debt Rs m21,73141,115 52.9%   
Total assets Rs m81,620142,432 57.3%  
Interest coverage x-0.14.0 -2.7%   
Debt to equity ratio x0.80.9 85.7%  
Sales to assets ratio x0.50.4 114.5%   
Return on assets %-5.06.9 -72.8%  
Return on equity %-23.414.7 -159.4%  
Return on capital %-7.714.2 -54.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80714,580 67.3%   
Fx outflow Rs m1,7893,600 49.7%   
Net fx Rs m8,01910,980 73.0%   
CASH FLOW
From Operations Rs m6848,942 7.7%  
From Investments Rs m6,302-47,070 -13.4%  
From Financial Activity Rs m-7,69534,174 -22.5%  
Net Cashflow Rs m-664-3,655 18.2%  

Share Holding

Indian Promoters % 74.5 71.5 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 7.0 32.8%  
FIIs % 7.7 12.6 61.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 8.8 175.0%  
Shareholders   67,757 26,511 255.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Lower; Banking and Automobile Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Apr 23, 2019 03:35 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS